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A Dynamic Molecular Link
between the Telomere Length Regulator TRF1
and the Chromosome End Protector TRF2
homodimerization [12, 14]. The proteins do not form
heterodimers [12]. Although related, the two proteins
have very different functions at telomeres. TRF1 func-
tions as a negative regulator of telomere length, acting
in cis to control access of telomerase [9, 15], whereas
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New York, New York 10016 TRF2 serves a protective function, preventing telomeres
from being viewed as double-strand breaks [16, 17].
According to the protein-counting model for telomere
length regulation [10, 18], long telomeres recruit moreSummary
TRF1, blocking access to telomerase. Conversely, short
telomeres recruit less TRF1, permitting access to telom-Background: Human telomeres are coated by the telo-
erase. A number of TRF1 binding partners, which canmere repeat binding proteins TRF1 and TRF2, which are
influence this negative feed back loop, have been identi-believed to function independently to regulate telomere
fied. Tankyrase 1, a member of the poly(ADP-ribose)length and protect chromosome ends, respectively.
polymerase (PARP) family of enzymes [19], binds to andResults: Here, we show that TRF1 and TRF2 are linked
ADP-ribosylates TRF1 in vitro, inhibiting its ability tovia TIN2, a previously identified TRF1-interacting pro-
bind telomeric DNA [20]. Overexpression of tankyrasetein, and its novel binding partner TINT1. TINT1 localized
1 in the nucleus induces loss (and subsequent ubiquiti-to telomeres via TIN2, where it functioned as a negative
nation and degradation) of TRF1 from telomeres, as wellregulator of telomerase-mediated telomere elongation.
as promotes telomerase-dependent telomere elonga-TIN2 associated with TINT1, and TRF1 or TRF2 through-
tion [21–23]. Thus, tankyrase 1 mimics a TRF1 dominantout the cell cycle, revealing a partially redundant unit
negative allele [9]; both strip TRF1 off telomeres,in telomeric chromatin that may provide flexibility in
allowing access to telomerase.telomere length control. Indeed, when TRF1 was re-
Another TRF1 binding protein, TIN2, has a novel pri-moved from telomeres by overexpression of the positive
mary structure with no known domains [24]. Overexpres-telomere length regulator tankyrase 1, the TIN2/TINT1
sion of the carboxy terminal TRF1 binding domain ofcomplex remained on telomeres via an increased asso-
TIN2, TIN2-13, results in telomerase-dependent telo-ciation with TRF2.
mere elongation [24]. Unlike nuclear tankyrase 1 [21]Conclusions: Our findings suggest a dynamic cross
and dominant negative TRF1 [9], TIN2-13 overexpres-talk between TRF1 and TRF2 and provide a molecular
sion does not induce loss of TRF1 from telomeres [24],mechanism for telomere length homeostasis by TRF2
suggesting that the deleted TIN2 amino terminal domainin the absence of TRF1.
might normally relay a negative signal from TRF1 to
telomerase. Consistent with this notion, knockdown of
Introduction TIN2 expression resulted in telomere elongation [25].
POT1, a highly conserved protein, was initially identi-
Telomere integrity is essential for growth of normal hu- fied based on its homology to ciliate proteins [26]. POT1
man cells, and telomere length maintenance plays a role binds to the 3 G-rich overhang at chromosome ends
in aging and cancer [1, 2]. Mammalian telomeres consist [26, 27] via an oligosaccharide/olignucleotide binding
of tandem arrays of TTAGGG repeats and associated (OB) domain. In addition, POT1 binds along the double-
proteins that function to protect and replicate the telo- strand length of the telomere by association with the
meric DNA. Telomere length maintenance depends TRF1 complex [28]. Overexpression of a POT1 allele
upon telomerase, a reverse transcriptase that adds telo- lacking the DNA binding domain, POT1OB, induced dra-
meric repeats to chromosome ends [3, 4]. Most normal matic telomere elongation [28, 29]. Again, as for TIN2-
human cells lack sufficient levels of telomerase to main- 13, telomere elongation occurred even though TRF1 re-
tain telomere length, hence telomeres shorten over time mained on telomeres [28], suggesting that the deleted
and result in replicative senescence [5, 6]. By contrast, in OB domain of POT1 might normally relay a negative
most human tumor cells, telomerase is highly expressed signal from TRF1 to telomerase by binding the 3 over-
[7], and telomere length is maintained at a constant hang and blocking telomerase access [28].
length setting [8, 9]. In addition to telomerase, telomere Even though these studies establish TRF1 as the link
length maintenance depends upon proteins that act in between telomeric DNA and proteins that regulate tel-
cis at individual chromosome ends to control recruit- omerase access, a number of observations raise the
ment or access to telomerase [10]. possibility that TRF2 could play a similar role. First, when
Mammalian telomeres are bound by the double- TRF1 is removed from telomeres (via a dominant nega-
strand DNA binding proteins TRF1 and TRF2 [11–13]. tive TRF1 allele or nuclear tankyrase 1), telomeres
These proteins are related in their primary structure; lengthen but eventually stabilize at a new length setting
both contain a carboxy terminal Myb-type DNA binding [9, 21, 22]. Thus, negative regulation of telomere length
motif and an internal dimerization domain required for occurs even in the absence of TRF1, indicating an alter-
nate or redundant telomere length regulation pathway
perhaps through TRF2. Second, overexpression of a*Correspondence: smithsu@saturn.med.nyu.edu
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Figure 1. TIN2 Binds TRF2 In Vivo
(A) Schematic representation of TIN2 and TRF2. TRF1BD, TRF1 binding domain; NLS, nuclear localization signal; myb, myb-type DNA binding
motif. TIN2-13 indicates the amino terminally deleted allele of TIN2 that induces telomere elongation. TIN2C indicates the carboxy terminal
domain expressed in HTC75 cells. Bait indicates the clone used in the two-hybrid screen. Prey indicates the single full-length isolate of TRF2.
(B) TRF2 is coimmunoprecipitated by TIN2 not TIN2C. Stable HTC75 cell lines expressing vector (V), FlagTIN2, or FlagTIN2C were lysed and
immunoprecipitated (IP) with anti-Flag beads. Proteins were fractionated on SDS-PAGE and analyzed by immunoblotting with anti-Flag, anti-
TRF1 415, or anti-TRF2.
(C) Endogenous TRF2 and TIN2 coimmunoprecipitate. HeLaI.2.11 cells were lysed and immunoprecipitated (IP) with IgG (anti-Flag as control
[C] or anti-TRF2) or with serum (normal serum as control [C] or anti-TRF1). Proteins were fractionated on SDS-PAGE and analyzed by
immunoblotting with anti-TRF2, anti-TRF1 415, or anti-TIN2 701. Input indicates 4% of input extract.
(D) Evidence for a ternary complex of TRF1, TRF2, and TIN2. Stable HTC75 cells expressing FlagTIN2 were cotransfected with plasmids
encoding MycTRF2 and TRF1. Cell lysates were immunoprecipitated (IP) with anti-Flag beads, anti-Myc beads, anti-TRF1 415, or IgG. Proteins
were fractionated on SDS-PAGE and analyzed by immunoblotting with anti-TIN2 701, anti-Myc, or anti-TRF1 415. Input indicates 4% of input
extract.
number of alleles of RAP1 (a TRF2 binding protein) in TRF2 (Figure 1A) and a novel uncharacterized protein
(hypothetical protein 24432; GenBank accession #HTC75 cells induces telomerase-dependent telomere
elongation [30–32]. BC016904), which we named TINT1 for TIN2 interacting
protein 1 (Figure 2A).Here, we provide a molecular connection between
TRF1 and TRF2 and potentially for telomere length main- Because TIN2 was previously characterized as a
TRF1-interacting protein, we sought to substantiate thetenance as well. We show that TIN2, along with an asso-
ciated novel telomere length regulator TINT1, binds to TIN2-TRF2 interaction by immunoprecipitation analysis.
Whole cell extracts from stable HTC75 cell lines express-both TRF1 and TRF2. Our studies indicate a dynamic
cross talk between TRF1 and TRF2; when TRF1 is re- ing Flag-epitope-tagged full-length TIN2 or an amino
terminally deleted form (TIN2C) (Figure 1A) were immu-moved from telomeres, association of TIN2 and TINT1
with TRF2 is increased. Increased binding of the TIN2/ noprecipitated with anti-Flag antibody and analyzed by
immunoblot. As shown in Figure 1B, both TRF1 andTINT1 complex to TRF2 could act as a signal to commu-
nicate changes in TRF1 levels and to ultimately establish TRF2 coimmunoprecipitated with full-length TIN2 (lane
2). TRF2 did not coimmunoprecipitate with TIN2C (lanea new telomere length setting in the absence of TRF1.
3), indicating that the amino terminal domain of TIN2 was
required for the TRF2 interaction. Interestingly, TRF2Results
showed a positive interaction with TIN2C in a two-hybrid
assay (data not shown). However, because this interac-TIN2 Binds TRF2
tion was not substantiated by coimmunoprecipitationPrevious work indicated that overexpression of an
analysis (Figure 1B, lane 3), its physiological relevanceamino terminally deleted form of TIN2, TIN2-13, (Figure
is unclear. To determine if the endogenous proteins were1A) resulted in dramatic telomere lengthening [24], rais-
complexed in cells, immunoprecipitation analysis wasing the possibility that the deleted amino terminal do-
performed on HeLaI.2.11 cells. As shown in Figure 1C,main of TIN2 might normally interact with proteins to
endogenous TIN2 coimmunoprecipitated with endoge-negatively regulate telomere length. A two-hybrid screen
nous TRF2 (lane 3) or TRF1 (lane 5).using this domain as bait resulted in identification of two
proteins: the previously characterized telomeric protein, The observation that TIN2 contained distinct binding
A Molecular Link between TRF1 and TRF2
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Figure 2. Identification, Expression, and Sub-
cellular Localization of TINT1, a Novel TIN2-
Interacting Protein
(A) Schematic representation of TIN2 and
TINT1. TRF1BD, TRF1 binding domain; TIN2BD,
TIN2 binding domain; SRD, serine rich do-
main. Bait indicates the clone used in the two-
hybrid screen. Prey indicates three unique
isolates of TINT1.
(B) Northern blot of polyadenylated RNAs
from the indicated human tissues (Clontech)
probed with a TINT1 cDNA or -actin.
(C) Characterization of anti-TINT1 antibodies.
Whole cell extracts from HTC75 cells ex-
pressing vector (V) or MycTINT1 (T) were ana-
lyzed by immunoblotting with anti-Myc, anti-
TINT1 880 (raised against a TINT1 peptide),
or anti-TINT1 911 (raised against a TINT1-
GST fusion protein) antibodies. PreI, preim-
mune serum; I, immune affinity purified IgG.
(D) Localization of TINT1 to the nucleoplasm
and to telomeres. Immunofluorescence anal-
ysis of paraformaldehyde-fixed HeLaI.2.11
cells stained with anti-TINT1 880 (green) and
anti-TIN2 701 (red). DAPI staining of the DNA
is blue.
sites for TRF2 (in its amino terminus) and TRF1 (in its in a variety of human tissues (Figure 2B), similar to other
human telomeric proteins [12, 13, 24].carboxy terminus) raised the possibility of a ternary com-
plex containing all three proteins. However, as shown To further characterize TINT1, rabbit polyclonal anti-
bodies were generated against a synthetic peptide ofin Figure 1C, TRF1 did not coimmunoprecipitate with
TRF2 (lane 3), nor did TRF2 coimmunoprecipitate with TINT1 amino acids 466–496 (rabbit anti-TINT1 880) or
against recombinant glutathione S-transferase (GST)TRF1 (lane 5), suggesting that TRF1 and TRF2 were
not in a ternary complex with TIN2. Indeed, a ternary fusion protein containing TINT1 amino acids 89–544
(rabbit anti-TINT1 911). Immunoblot analysis indicatedcomplex was only observed under conditions where all
three proteins (TRF1, TRF2, and TIN2) were overex- that the affinity purified TINT1 antibodies specifically
detected exogenously expressed Myc-epitope-taggedpressed (Figure 1D and data not shown), suggesting
that (at least under our immunoprecipitation conditions), TINT1, MycTINT1 (Figure 2C, lanes 6 and 10), as well
as an endogenous protein (Figure 2C, lanes 5, 6, 9, anda ternary complex is either unstable or rare.
10) which migrated at approximately 58 kDa, consistent
with the predicted molecular weight of TINT1. Immuno-TIN2 Binds a Novel Telomeric Protein, TINT1
fluorescence analysis of HeLaI.2.11 cells with the anti-We next turned to characterization of the second TIN2
peptide antibody TINT1 880 revealed a diffuse nuclearinteracting protein, TINT1 (Figure 2A). Analysis of its
and punctate telomeric staining pattern, which cos-primary structure showed no homology to previously
tained with TIN2 (Figure 2D). Anti-TINT1 911 gave a simi-characterized proteins in the database. A search for
lar telomeric staining pattern.known protein motifs uncovered a serine rich domain
(SRD) between amino acids 354 and 442. The TIN2 bind-
ing domain (TIN2 BD), based on the smallest TINT1 clone TINT1 Is a Negative Regulator of Telomere Length
To assess the role of TINT1 in telomere length regulation,isolated in the two-hybrid screen, mapped between
amino acids 428 and 544 (Figure 2A). Northern blot anal- several different Myc-epitope-tagged alleles of TINT1
were created (Figure 3A) and used for generating stableysis indicated that TINT1 was ubiquitously expressed
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Figure 3. The Carboxy Terminal Domain of TINT1 Is Required for Interaction with TIN2 and for Localization to Telomeres
(A) Schematic diagram of Myc-epitope-tagged TINT1 alleles.
(B) Immunoprecipitation analysis of TINT1 alleles. Stable HTC75 cell lines expressing vector (V), MycTINT1, MycTINT188, MycTINT1274, or
MycTINT1426 were lysed, and immunoprecipitated (IP) with anti-Myc beads. Proteins were fractionated on SDS-PAGE and analyzed by
immunoblotting with anti-Myc or anti-TIN2 701 antibodies.
(C) Subcellular localization of TINT1 alleles. Immunofluorescence analysis of paraformaldehyde-fixed HeLaI.2.11 cells after transfection for 24
hr with MycTINT1 (Ca), MycTINT188 (Cb), MycTINT1274 (Cc), or MycTINT1426 (Cd). Cells were stained with anti-Myc 9E10 (Ca–Cd) (green) and anti-
TRF1 415 (Ca and Cb) or anti-TINT1 880 (Cc and Cd) (red). DAPI staining of the DNA is blue.
(D) TINT1 coimmunoprecipitates TRF1 and TRF2. Stable HTC75 cell lines expressing vector (V) or MycTINT1 (TINT1) were lysed and immunopre-
cipitated (IP) with anti-Myc beads. Proteins were fractionated on SDS-PAGE and analyzed by immunoblotting with anti-TINT1 880, anti-TIN2
701, anti-TRF1 415, or anti-TRF2 antibodies. Input indicates 4% of input extract.
HTC75 cell lines. TINT1 alleles containing the TIN2 bind- sulted in a progressive telomere shortening, indicating
TINT1 as a negative regulator of telomere length. Cellsing domain (MycTINT1 and MycTINT188) (Figure 3A)
coimmunoprecipitated TIN2 (Figure 3B, lanes 2 and 3) overexpressing MycTINT188 or MycTINT1274 also dis-
played telomere shortening, but here, telomere lengthand localized to telomeres (as evidenced by the punc-
tate nuclear staining pattern and colocalization with stabilized and eventually slightly lengthened. In contrast
to the other three alleles, overexpression of MycTINT1426TRF1) (Figures 3Ca and 3Cb). By contrast, TINT1 alleles
lacking the TIN2 binding domain (MycTINT1274 and Myc- resulted in progressive telomere elongation. To deter-
mine if MycTINT426 was acting as a dominant negativeTINT1426) (Figure 3A) did not coimmunoprecipitate TIN2
(Figure 3B, lanes 4 and 5), and showed a diffuse nucleo- allele (i.e., promoting telomere lengthening by inhibiting
endogenous TINT1), TINT1426-overexpressing cells wereplasmic staining pattern (Figure 3Cc and 3Cd). Together,
these data confirm that the carboxy terminal domain of costained with anti-TINT1 880 anti-peptide antibody
(which detects endogenous TINT1 but not exogenousTINT1 (amino acids 427–544) is required for binding
to TIN2 and further suggest that the TIN2 interaction MycTINT1426). As shown in Figure 3Cd, endogenous
TINT1 was unaffected, indicating that MycTINT1426 doesis required for localization of TINT1 to telomeres. To
determine if TINT1 was complexed with TRF1 or TRF2, not promote telomere elongation by removing endoge-
nous TINT1 from telomeres.MycTINT1 immunoprecipitates were analyzed by immu-
noblot. As shown in Figure 3D, MycTINT1 coimmuno- To determine if the aforementioned TINT1 telomere
length effects were dependent on telomerase, TINT1precipitated TIN2, TRF1, and TRF2, indicating that the
TIN2/TINT1 complex is bound to both TRF1 and TRF2. alleles were expressed in human primary WI38 cells.
As shown in Figure 4C, overexpression of TINT1 andThe stable HTC75 cell lines expressing MycTINT1 al-
leles were carried for 144 population doublings (PD) TINT1274 did not increase the rate of telomere shortening
compared to a vector control. Conversely, TINT1426 didand subjected to telomere length analysis. As shown in
Figures 4A and 4B, overexpression of MycTINT1 re- not induce telomere lengthening. These results indicate
A Molecular Link between TRF1 and TRF2
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Figure 4. TINT1 Regulates Telomere Length
(A) Analysis of telomere restriction fragments isolated from stable HTC75 cell lines expressing vector, MycTINT1, MycTINT188, MycTINT1274,
or MycTINT1426 at the indicated population doublings (PD) and fractionated on agarose gels. Native gels were hybridized to a 32P end-labeled
(CCCTAA)4 oligonucleotide probe.
(B) Graphical representation of telomere length changes in the stable HTC75 cell lines expressing the indicated alleles. Plots represent the
mean telomere length values derived from the Southern blots in (A).
(C) Analysis of telomere restriction fragments isolated from stable WI38 cell lines expressing vector, MycTINT1, MycTINT1274, or MycTINT1426
at the indicated population doublings (PD) and fractionated on agarose gels. Native gels were hybridized to a 32P end-labeled (CCCTAA)4
oligonucleotide probe.
(D) Graphical representation of the effect of TINT1 overexpression on WI38 cell growth. Cell growth was monitored and plotted as population
doublings versus days in culture.
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Figure 5. TIN2 Is Complexed with TINT1, TRF1, and TRF2 across the Cell Cycle
(A) FACS analysis of synchronized FlagTIN2 HTC75 cells. y axis, cell numbers; x axis, relative DNA content based on propidium iodide staining.
Asyn, asynchronous; cells were released for 0–14 hr from a double-thymidine block.
(B) Immunoprecipitation of FlagTIN2 across the cell cycle. Stable HTC75 cell lines expressing vector (V) or FlagTIN2 from the indicated times
after release from a double-thymidine block or from asynchronous cultures (A) were lysed, and immunoprecipitated (IP) with anti-Flag beads.
Proteins were fractionated on SDS-PAGE and analyzed by immunoblotting with anti-TIN2 701, anti-TRF1 415, anti-TRF2, and anti-TINT1 880
antibodies.
that the telomere length effects induced by TINT1 alleles [21]. As shown in Figure 6A and previously shown in [21],
overexpression of tankyrase 1 in the nucleus removeddepend upon telomerase, consistent with TINT1 affect-
TRF1 from telomeres. This is a very robust reaction ining the cis-acting telomerase-dependent pathway of
which the majority of cells overexpressing tankyrase 1telomere length control. Interestingly, although expres-
show a complete loss of telomeric TRF1. For example,sion of TINT1 alleles had no effect on the growth rate
out of 200 tankyrase-1-overexpressing cells, 95%of HTC75 cells (data not shown), it did influence the
showed a complete loss of TRF1, and 5% were unaf-growth of WI38 cells. As shown in Figure 4D, the WI38-
fected. By contrast, in most tankyrase-1-overexpressingTINT1 cell lines (in particular TINT1426) grew more slowly
cells, some TIN2 remained on telomeres (Figures 6Abthan the vector control, indicating that TINT1 overex-
and 6Ab). Only 7% of the transfected cells showed apression can influence the growth rate of human primary
complete loss of TIN2, 76% showed a partial loss (i.e.,cells.
some TIN2 remained on telomeres), and 17% were unaf-
fected. Similarly, costaining of tankyrase-1-overex-
TIN2, TINT1, TRF1, and TRF2 Are Complexed pressing cells with TINT1 showed that TINT1 remained
Across the Cell Cycle associated with telomeres in the absence of TRF1 (Fig-
Our studies thus far indicate that TIN2 is bound to three ures 6Ac and 6Ac). Finally, we used triple immunofluores-
telomeric proteins, TRF1, TRF2, and TINT1. To deter- cence analysis to visualize TRF1 and TIN2 or TINT1 in
mine if TIN2 interaction with these three proteins varied the same tankyrase-1-overexpressing cell. As shown in
during the cell cycle, FlagTIN2 cells were arrested in S Figure 6B, in cells overexpressing tankyrase 1 (Figure
phase by a double thymidine block. After release from 6Ba), TRF1 was removed from telomeres (Figure 6Ba),
arrest, cells progressed synchronously through S and whereas in the same cells, TIN2 remained bound (Figure
G2/M, as shown by FACS analysis (Figure 5A). Immu- 6Ba″). Similar results were obtained for TINT1 (Figures
noblot analysis of FlagTIN2 immunoprecipitates, from 6Bb, 6b, and 6b″).
either asynchronous or cell cycle staged extracts, The association between the TIN2/TINT1 complex and
showed coimmunoprecipitation of TRF1, TRF2, and TRF2 in the absence of TRF1 was confirmed by immuno-
precipitation analysis. Here, we took advantage of aTINT1 (Figure 5B), indicating that these proteins are
previously generated HTC75 cell line, FN30, which ex-complexed throughout the cell cycle.
presses a doxycyclin-inducible allele of FN-tankyrase 1
[21]. As shown in Figure 6C, lane 2, overexpression of
The TIN2/TINT1 Complex Associates with TRF2 tankyrase 1 induced degradation of TRF1 but had no
and Telomeres in the Absence of TRF1 effect on TRF2 or TINT1. However, we did observe a
Our results suggest a partially redundant unit at telo- small but reproducible increase in TIN2 levels. Immuno-
meres of TIN2 and TINT1 bound to TRF1 or TRF2. If precipitation analysis indicated an increased associa-
true, the prediction is that TIN2 and TINT1 could remain tion between TRF2 and the TIN2/TINT1 complex in the
associated with telomeres via TRF2 even in the absence absence of TRF1: TIN2 coimmunoprecipitated increased
of TRF1. To address this question, we determined the levels of TRF2, TRF2 coimmunoprecipitated increased
fate of TIN2 and TINT1 when TRF1 was removed from levels of TIN2 and TINT1, and TINT1 coimmunoprecipi-
telomeres by tankyrase 1 overexpression. For this, we tated increased levels of TRF2 (Figure 6C, lane 2). The
used a Flag-epitope-tagged allele of tankyrase 1, which increased association is not the result of telomere length
changes as it occurs after short-term induction of tan-contained a nuclear localization signal, FN-tankyrase 1
A Molecular Link between TRF1 and TRF2
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Figure 6. TIN2 and TINT1 Remain Associated with TRF2 at Telomeres in the Absence of TRF1
(A and B) Immunofluorescence analysis of tankyrase-1-overexpressing cells. HeLaI.2.11 cells were paraformaldehyde-fixed following 18 hr
transfection with FN-Tankyrase 1. For double immunofluorescence, (A) cells were stained with anti-Flag (Aa, Ab, and Ac) (green) and anti-TRF1
415 (Aa), anti-TIN2 701 (Ab), or anti-TINT1 911 (Ac) (red). DAPI staining of the DNA is blue. For triple immunofluorescence, (B) cells were
stained with anti-ECS/Flag (Ba and Bb) (blue), anti-TRF1 415 (Ba and Bb) (red), and anti-TIN2 701 (Ba″) or anti-TINT1 911 (Bb″) (green).
(C and D) Immunoprecipitation analysis of tankyrase 1 cell lines. (C) FN30 (HTC75 cells expressing inducible FN-tankyrase 1) grown in the
absence or presence of doxycylin or (D) HTC75 cells constitutively expressing a vector control pLPC (V), FN-tankyrase 1 wild-type (WT), or
PARP-dead (HE/A) were lysed and immunoprecipitated (IP) with anti-TIN2 701, anti-TRF2, anti-TINT 880 antibodies, or control (anti-rabbit IgG
or mouse serum). Proteins were fractionated on SDS-PAGE and analyzed by immunoblotting with anti-tankyrase 1 465, anti-TRF1 415, anti-
TRF2, anti-TIN2 701, or anti-TINT1 911 (indicated to the right of each blot). The asterisk indicates a nonspecific band observed in control
immunoprecipitates blotted with anti-TRF1 415 antibody. Input indicates 4% of input extract.
kyrase 1 before any significant telomere elongation oc- absence of TRF1, and the data further suggest that asso-
ciation between the TIN2/TINT1 complex and TRF2 iscurs [21].
Identical results were obtained with a different set of increased in cells that overexpress tankyrase 1 and con-
tain reduced levels of TRF1.HTC75 stable cell lines, which constitutively express
wild-type (WT) or catalytically PARP-dead (HE/A) FN-
tankyrase 1 [22]. As shown in Figure 6D, overexpression
of tankyrase 1 WT (lane 2), but not tankyrase 1 HE/A Discussion
(lane 3) or vector control (lane 1), induced degradation of
TRF1 but not TRF2, TINT1, or TIN2. Immunoprecipitation Mammalian telomeric chromatin consists of tandem
arrays of TTAGGG repeats bound to the double-strandanalysis indicated increased association between TRF2
and the TIN2/TINT1 complex in tankyrase 1 WT cells (in DNA binding proteins TRF1 and TRF2. These two pro-
teins do not interact with each other directly; they havewhich TRF1 was degraded) (Figure 6D, lane 2) but not
in the vector control (Figure 6D, lane 1) or PARP-dead each previously been thought to associate with a unique
set of proteins to execute discrete functions at telo-HE/A cells (Figure 6D, lane 3). Together, the immunofluo-
rescence analysis and coimmunoprecipitation data pre- meres. Our studies show that they do, in fact, associate
with a common set of telomere length regulators TIN2sented in Figure 6 demonstrate that TIN2 and TINT1
can remain associated with TRF2 at telomeres in the and TINT1, suggesting a molecular mechanism for cross
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Moreover, like TRF1 [15, 33], TINT1 had no effect on
telomere shortening in telomerase-negative primary
cells (Figure 4C), suggesting that TINT1 acts in cis at
telomeres to block access of telomerase. While this pa-
per was under review, TINT1 was independently identi-
fied as PTOP [34] or PIP1 [35] by mass spectrometric
analysis of TIN2 immunoprecipitates, where it was found
that in addition to TIN2, TINT1 (PTOP/PIP1) also bound
to POT1. Knockdown of TINT1 (PTOP/PIP1) expression
resulted in telomere elongation [35], consistent with a
role as a negative regulator of telomere length.
We showed that TINT1 associated with TIN2 (and lo-
calized to telomeres) via its carboxy terminal amino
acids 427–544 (Figures 3B and 3C). Overexpression of
an allele lacking this domain, TINT1426, promoted telo-
mere elongation (Figures 4A and 4B). TINT1426 did not
localize to telomeres but rather exhibited a diffuse nu-
cleoplasmic stain (Figure 3Cd). It will be important to
determine how TINT1426 exerts its effect at telomeres.
The finding that its overexpression had no effect on
localization of endogenous TINT1 (Figure 3Cd) makes
Figure 7. A Hypothetical Model for Telomere Length Regulation by a dominant negative effect unlikely. Of the two alleles
TRF2 in the Absence of TRF1 lacking the TIN2 binding domain (TINT1274 and TINT1426),
TINT1, a negative regulator of telomere length, associates with TRF1 only TINT1426 induced telomere elongation, implicating
or TRF2 via TIN2. When TRF1 is removed from telomeres, the TIN2/
amino acids 275 to 426 in telomere elongation. Interest-TINT1 complex can remain on telomeres via an increased associa-
ingly, amino acids 244–337 of TINT1 (PTOP/PIP1) [34]tion with TRF2. Eventually, TRF2 can recruit enough TINT1 to block
were identified as the POT1 recruiting domain, and thisaccess to telomerase and establish a new telomere length setting.
domain alone was shown to induce telomere elongation
[34]. Thus, based on these findings, TINT1426 could act
talk between TRF1 and TRF2 and for a flexibility or re- by stripping POT1 off telomeres and allowing access
dundancy in telomere length regulation. to telomerase. Although TINT1426 had no effect on the
growth rate of telomerase positive HTC75 cells, it did
TIN2 Binds TRF1 and TRF2 dramatically slow the growth rate of primary WI38 cells.
Our data indicate that TIN2 contains, in addition to the It is interesting to speculate that this same activity of
previously reported TRF1 binding site in its carboxy ter- TINT1426 (removal of POT1 from telomeres) could have
minus [24], a TRF2 binding site in its amino terminus. a differential effect on cells, depending on their telom-
We demonstrate by coimmunoprecipitation analysis of erase status.
endogenous proteins that TIN2 is complexed with either Two other alleles, TINT188 and TINT1274, promoted
TRF1 or TRF2 (Figure 1C). Under our immunoprecipita- telomere shortening but not to the same extent as full-
tion conditions, only a small fraction of the total TIN2 in length TINT1 (Figures 4A and 4B). The observation that
the cell is complexed to TRF1 or TRF2. However, this full-length TINT1 promotes a more dramatic shortening
is likely to be an underestimate of the amount in vivo. than TINT188 suggests that the amino terminal 88 amino
Indeed, when cells are fractionated into nuclear and acids could play some role in telomere length regulation.
cytosolic extracts by hypotonic dounce lysis, whereas Similarly, the finding that TINT1274 can influence telomere
TRF1 and TRF2 fractionate exclusively with nuclei, as length (despite the fact that it lacks both the POT1-
much as half of the TIN2 leaks out into the cytosol (W.C., and TIN2-interacting domains) suggests that the amino
S.S., unpublished data), indicating a highly unstable as- terminal 274 amino acids could interact with other pro-
sociation. Similarly, although we could immunoprecipi- tein(s) that might influence telomere length.
tate a ternary complex of TIN2, TRF1, and TRF2, it ap-
peared to be minor, and it required simultaneous The TIN2/TINT1 Complex Associates
overexpression of all three proteins (Figure 1D). Again, with TRF1 or TRF2
such a ternary complex may be more prevalent in vivo Our immunoprecipitation and immunofluorescence analy-
but fall apart upon cell lysis. It will be important in the ses indicate that the TIN2/TINT1 complex associates
future to determine the stability and characteristics of with TRF1 or TRF2 at telomeres. This association occurs
these complexes in vivo. This may be achieved through throughout the cell cycle, indicating these complexes
a combination of in vivo crosslinking, subsequent frac- as persistent units of telomeric chromatin (Figure 5).
tionation, and gradient sedimentation. Moreover, we demonstrate that association of the com-
plex with TRF1 or TRF2 is dynamic; in cells overexpress-
TINT1, a Novel Telomere Length Regulator ing tankyrase 1, there is an increased association be-
Overexpression of full-length TINT1 in HTC75 cells re- tween the TIN2/TINT1 complex and TRF2 (Figures 6C
sulted in telomere shortening of approximately 11 bp and 6D). We propose that this increased association of
per PD (Figures 4A and 4B), similar to the rate previously the TIN2/TINT1 complex with TRF2 may serve to regu-
late telomere length in the absence of TRF1.shown for TRF1 overexpression (3–10 bp per PD) [9].
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Yeast Two-Hybrid ScreenConclusions
A two-hybrid screen was performed with the yeast reporter strain
L40 [37] with a HeLa cDNA library (Clontech) and the LexA-TIN2We consider our results in terms of a hypothetical model
bait plasmid according to Clontech Matchmaker protocol. Of 15
shown in Figure 7. Normally, TRF1 and its associated positive clones, 11 contained TINT1 cDNA of varying sizes as indi-
factors, TIN2 and TINT1, negatively regulate telomere cated in Figure 2A. One contained full-length TRF2 cDNA.
length by blocking access to telomerase. When TRF1
Whole Cell Extractsis removed from telomeres (via a dominant negative
Whole cell extracts from HTC75 cells stably expressing a vectorTRF1 allele or nuclear tankyrase 1), telomeres lengthen
pLPC or MycTINT1 were prepared as described [22].but eventually stabilize at a new length setting [9, 21, 22].
How can telomere length be reset without the negative
Immunoprecipitations
regulation of TRF1 and its associated proteins? One Cells were lysed (per one 15-cm-diameter dish) in 0.5 ml TNE buffer
possibility is that the freed TIN2/TINT1 complex could (10 mM Tris [pH7.8], 1% Nonidet P-40, 0.15 M NaCl, 1 mM EDTA,
and protease inhibitor cocktail [Sigma]) on ice for 1 hr, then pelletedassociate with TRF2 to block access to telomerase and
at 8,000  g for 10 min. Supernatants were precleared with normaleventually establish a new telomere length setting. The
mouse or rabbit serum or rabbit immunoglobulin (IgG) and proteinrecent demonstration of TINT1 (PTOP/PIP1) as a POT1
G-Sepharose rotating at 4C for 30 min. Nonspecific antibody com-binding protein [34, 35] suggests a mechanism for how
plexes and protein aggregates were removed by centrifugation, and
the TIN2/TINT1 complex could block access to telom- the supernatant was used for immunoprecipitation analysis or frac-
erase (i.e., by recruiting POT1 to the 3 overhang). POT1 tionated directly on SDS-PAGE (indicated as input, approximately
4% of the amount used in the immunoprecipitation). Supernatantswas found to associate with TRF1 by coimmunoprecipi-
were incubated with 0.35–1.0 g of rabbit IgG, mouse anti-Flagtation [28], presumably through the TIN2/TINT1 com-
(Sigma), rabbit anti-TRF1 415, rabbit anti-TIN2 701, rabbit anti-TINT1plex. Whether POT1 associates with TRF2 in this same
880, or mouse anti-TRF2 (Imgenex) IgG, or with .5–1l normal mouseway remains to be determined.
or mouse anti-TRF1 serum at 4C with rocking for 2.5 hr. Antigen-
The scenario described above provides a mechanism antibody complexes were collected on protein G beads at 4C with
for telomere length homeostasis in the absence of TRF1 rocking for 30 min. In the case of rabbit anti-Myc-agarose bead
conjugates (Sigma) or mouse anti-Flag-agarose bead conjugatesunder conditions in which a telomeric protein (such as
(Sigma), following the preclear, the supernatant was incubated withdominant negative TRF1 or nuclear tankyrase 1) is over-
35 l of beads at 4C with rocking for 3 hr. Protein G antibodyexpressed. What role might this shared complex be-
complexes or antibody-agarose bead conjugates were then washedtween TRF1 and TRF2 serve under normal steady state
three times with 1.0 ml TNE buffer and suspended in Laemmli buffer.
conditions? One possibility could be communication be- Samples were either boiled or not boiled (to prevent the IgG from
tween TRF1 and TRF2. For example, during the course comigrating with TRF1 and TINT1), fractionated on a 10% SDS-
PAGE gel, and processed for immunoblotting as described below.of the cell cycle, TRF1 may be released from telomeres
transiently, perhaps to allow access to telomerase or
Immunoblottingpassage of the replication fork. The freed TIN2/TINT1
Proteins were electrophoretically transferred to nitrocellulose andcomplex could associate with TRF2, signaling changes
blocked in 5% milk in PBS containing 0.1% Tween 20. Blots were
in TRF1. The TIN2/TINT1 complex could also uniquely incubated with the following primary antibodies: rabbit anti-TRF1
affect TRF2’s protective function, perhaps contributing 415 (0.36 g/ml), rabbit anti-tankyrase1 465 (1.8 g/ml), mouse
to modulations in the protective complex that may occur monoclonal anti-TRF2 (2.0 g/ml) (Imgenex), rabbit anti-Myc (0.8
g/ml) (Santa Cruz Biotechnologies), mouse anti-Myc (2 g/ml) (Up-during telomere elongation or replication. Finally, the
state Biotechnology), mouse monoclonal anti-Flag M2 (4.4 g/ml)TIN2/TINT1 complex may play a general role in the orga-
(Sigma), rabbit anti-TIN2 701 (0.5 g/ml), rabbit anti-TINT1 880 (0.4nization of telomeric chromatin, coordinating both TRF1
g/ml), or rabbit anti-TINT1 911 (1.9 g/ml) followed by horseradish
and TRF2 along with telomeric DNA into a higher-order peroxidase-conjugated donkey anti-rabbit or anti-mouse IgG (Amer-
chromatin structure. Here, redundancy would allow the sham) (1:2500). Bound antibody was detected with Super Signal
telomeric chromatin structure to be maintained despite West Pico (Pierce) except in the case of TRF2 immunoblots in which
West Dura or West Femto Substrate (Pierce) were used.changes to either TRF1 or TRF2.
Transient TransfectionsExperimental Procedures
Transfections were performed with Lipofectamine 2000 regeant
(Invitrogen). FlagTIN2 HTC75 cells were cotransfected withPlasmids
pcDNA3hTRF1 (full-length untagged TRF1) and pcDNA3hTRF2 (full-The LexA-TIN2 two-hybrid bait consisted of human TIN2 cDNA
length amino terminally Myc-epitope-tagged TRF2) for 18 hr andamino acids 1 to 195 cloned into the pBTM116 vector [36].
processed for immunoprecipitation as described above. HeLaI.2.11FN-tankyrase 1 [21] consisted of an amino terminal Flag epitope
cells [16] were transfected with pcDNA3-FN-tankyrase1.WT for 18tag followed by a nuclear localization signal and human tankyrase
hr or MycTINT1, MycTINT188, MycTINT1274, or MycTINT1426 for 241 amino acids 2–1327 cloned into the pcDNA3 expression vector
hr and processed for immunofluorescence analysis as described(Invitrogen). The human TIN2 retroviral constructs consisted of an
below.amino terminal Flag epitope tag followed by TIN2 amino acids 2 to
354 (TIN2) or amino acids 180 to 354 (TIN2C) cloned into pBABEpuro
(a gift from S. Lowe). The human TINT1 retroviral constructs con- Indirect Immunofluorescence
Cells were processed for immunofluorescence as described pre-tained an amino terminal Myc epitope tag followed by amino acids
2–544 (TINT1), 89–544 (TINT188), 2–274 (TINT1274), or 2–426 (TINT1426) viously [22] with rabbit anti-TRF1 415 (0.36 g/mL; [22]), mouse
monoclonal anti-Flag M2 (0.9 g/mL; Sigma), rabbit anti-TIN2 701cloned into the retroviral vector pLPCX (Clontech). TINT1274 and
TINT1426 contain the following additional amino acids (IAAASAKHR; (0.5 g/ml), mouse anti-TIN2 (5 g/ml) (Imgenex), rabbit anti-TINT1
880 (0.4g/ml), rabbit anti-TINT1 911 (1.9g/ml), goat anti-ECS/Flagfrom the polylinker sequence in the pLPCX vector upstream of the
stop codon) at their carboxy termini. Amino terminal GST fusion (2g/ml; Bethyl Laboratories), mouse anti-TRF1 serum [20] (1:5000),
or mouse anti-Myc 9E10 supernatant (1:50) as primary antibodies.proteins consisted of TIN2 amino acids 1 to 354 (GST-TIN2) or TINT1
amino acids 89–544 (GST-TINT88) cloned into the pGEX-5X-1 vector Primary antibodies were detected with fluorescein isothiocyanate-
or tetramethyl rhodamine isothiocyanate-conjugated donkey anti-(Amersham Biosciences).
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rabbit or anti-mouse antibodies (1:100) (Jackson Laboratories) and stained with propidium iodide (50 g/ml) and analyzed with a Bec-
ton-Dickinson FACSCAN and Modfit 3.0 software.for triple immunofluorescence, with coumarin AMCA conjugated
donkey anti-goat antibody (1:100) (Jackson Laboratories). DNA was
stained with 4,6-diamino-2-phenylindole (DAPI) (0.2 g/ml) where Acknowledgments
applicable. Images were acquired on a Zeiss Axioplan 2 microscope
with a Photometrix SenSyn camera. Photographs were processed We thank Dominique Broccoli for the pcDNA3hTRF2 plasmid, Nicole
and merged using IPLab software. Jordan for technical assistance, and Tom Meier and members of
the Smith lab for comments on the manuscript. B.R.H. and L.C.
Retroviruses and Cell Lines. were supported by the National Institutes of Health Predoctoral
Amphotropic retroviruses were generated by transfection of pBABE- Training Program in Cell and Molecular Biology (GM07238) and Mo-
puro, pBABE-Flag-TIN2FL, pBABE-Flag-TIN2C, pLPC, pLPCX-Myc- lecular Oncology and Immunology (CA09161), respectively. This
TINT1FL, pLPCX-MycTINT188, pLPCX-MycTINT1274, or pLPCX- work was supported by a grant from the National Institutes of Health
MycTINT1426 into phoenix amphotropic cells with calcium phosphate (RO1 CA95099).
precipitation. HTC75 cells (an HT1080-derived clonal cell line [9]) or
WI38 cells (human primary fibroblasts at population doubling [PD] Received: August 3, 2004
35; American Type Culture Collection) were essentially infected as Accepted: August 4, 2004
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